Volume 18, Number 3—March 2012
Pathogenic Potential to Humans of Bovine Escherichia coli O26, Scotland
|Source||Country of origin||Analyses||No. isolates||Clinical information|
|Human‡||Scotland||MLST||11||D (n = 8); BD (n = 2); NK (n = 1)|
|Human¶||Italy||MLST||5||HC (n = 1); HUS (n = 4)|
|Human#||Germany||MLST||14||D (n = 6); HUS (n = 8)|
*NR, not relevant; PFGE, pulsed-field gel electrophoresis; MLST, multilocus sequence typing; NK, not known; D, diarrhea; BD, bloody diarrhea, HC, hemorragic colitis; HUS, hemolytic uremic syndrome. Where appropriate, the number of isolates from each clinical designation is provided.
†Isolated 2002–2004 (21).
‡L.J. Allison, Scottish E. coli O157/VTEC Reference Laboratory, Edinburgh, UK; isolated 2002–2003.
§H. Smith, Laboratory of Gastrointestinal Pathogens, Colindale, UK. The years isolated are unknown.
¶A. Caprioli, Instituto Superiore di Sanità, Rome, Italy. The years isolated are unknown.
#H. Karch, University of Műnster, Műnster, Germany; isolated 1994–2000.
- Page created: February 16, 2012
- Page last updated: February 16, 2012
- Page last reviewed: February 16, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)